MedTrace Logo

A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)

NCT00902200 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2014-04-21

No results posted yet for this study

Summary

Double-masked, randomized, multi-center, placebo-controlled parallel-comparison of AR-12286.

Conditions

  • Elevated Intraocular Pressure

Interventions

DRUG

AR-12286

See arms

DRUG

AR-12286 vehicle

See arms

Sponsors & Collaborators

  • Aerie Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Tom van Haarlem, MD · Aerie Pharmaceuticals, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00902200 on ClinicalTrials.gov